Mosaic ImmunoEngineering CPMV
OTC CPMV
$0.06 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Mosaic ImmunoEngineering (CPMV) EBITDA Margin (2010 - 2011)

Updated

Mosaic ImmunoEngineering (CPMV) posted EBITDA Margin of -1636.56% for Q2 2012, up 653.94 percentage points from -2290.49% a year earlier but down 1040.02 percentage points from the prior quarter.

Analysis

Mosaic ImmunoEngineering (CPMV) EBITDA Margin (2010 - 2011) Analysis & Trends

For the trailing twelve months through Nov 30, 2011, EBITDA Margin at Mosaic ImmunoEngineering was -1094.51%.

  • Quarterly EBITDA Margin has run from a low of -2290.49% in Q2 2011 to a high of -596.53% in Q1 2012 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 35.95%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 49.01%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 6.02%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 33.11%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 46.01%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -124.26%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 39.10%
10 Mosaic ImmunoEngineering 434,528.21 434,528.21 - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2011 -1,636.56%
Aug 31, 2011 -596.53%
Nov 30, 2010 -2,290.49%
Aug 31, 2010 -1,604.77%
API Access

Mosaic ImmunoEngineering EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CPMV&period=max&api_key=YOUR_API_KEY